Multiphase optimization strategy (MOST) – GOV.UK

This guidance is part of a guide to evaluating digital health products. Digital health products and services are usually made up of various features (multicomponent interventions). However, they are often assessed as a package and we are unable to tell which components of the interventions are effective and which are non-essential. Multiphase optimization strategy (MOST) …
Continue reading Multiphase optimization strategy (MOST) – GOV.UK

Interrupted time series study – GOV.UK

An interrupted time series (ITS) design involves collecting data consistently before and after an interruption. This means introducing and withdrawing your digital product or service, or some part of it. It is a useful design to demonstrate cause and effect of your digital product without randomising to different conditions – for example, as you would …
Continue reading Interrupted time series study – GOV.UK

Vaccination in pregnancy (VIP) – GOV.UK

The Immunisation department at Public Health England (PHE) follows up women who have been given certain vaccines in pregnancy (VIP). It analyses the details submitted by GPs and surgeries to better inform: pregnant women who are inadvertently immunised their families health professionals who are responsible for their care Notify PHE If you have patients who …
Continue reading Vaccination in pregnancy (VIP) – GOV.UK

Breast screening programme: standards – GOV.UK

Published 10 April 2017 Last updated 16 December 2020 + show all updates 16 December 2020 Added the ‘from 1 April 2021 onwards’ standards and updated the supporting information to link to these standards. 26 July 2019 Breast screening standards updated and reformatted. 15 August 2017 Added text to clarify which standards should be used for …
Continue reading Breast screening programme: standards – GOV.UK

Prescribed medicines review: report – GOV.UK

Published 10 September 2019 Last updated 3 December 2020 + show all updates 3 December 2020 Clarified that placebo-controlled trials looked at possible withdrawal symptoms in summary and report. Other minor amendments to report, including Appendix A. 10 September 2019 Added link to infographics slide pack. 10 September 2019 First published. Source link

MSSA bacteraemia: annual data – GOV.UK

Published 10 July 2014 Last updated 3 December 2020 + show all updates 3 December 2020 Added annual data for the financial year April 2019 to March 2020. 11 July 2019 Added annual data for the financial year April 2018 to March 2019. 12 July 2018 Added annual data for the financial year April 2017 to …
Continue reading MSSA bacteraemia: annual data – GOV.UK

MRSA bacteraemia: annual data – GOV.UK

Published 10 July 2014 Last updated 3 December 2020 + show all updates 3 December 2020 Added annual data for the financial year April 2019 to March 2020. 11 July 2019 Added annual data for the financial year April 2018 to March 2019. 12 July 2018 Added annual data for the financial year April 2017 to …
Continue reading MRSA bacteraemia: annual data – GOV.UK

PHE data release register – GOV.UK

Published 27 February 2019 Last updated 1 December 2020 + show all updates 1 December 2020 Added update: April 2017 to September 2020. 13 March 2020 Added April 2017 to January 2020 data update. 23 October 2019 Updated the PHE data release register. 22 May 2019 Updated the PHE data release register. 27 February 2019 First …
Continue reading PHE data release register – GOV.UK

Influenza vaccine: ovalbumin content – GOV.UK

Published 29 July 2016 Last updated 1 December 2020 + show all updates 1 December 2020 Ovalbumin content list updated. 10 June 2020 Added table for the 2020 to 2021 flu season. 4 July 2019 Updated title of document to ‘Influenza vaccines: 2019 to 2020 flu season.’ 3 July 2019 Updated with the vaccines for the …
Continue reading Influenza vaccine: ovalbumin content – GOV.UK